Although survival extension in xenograft models supports target engagement [4], PHGDH inhibition in MYCN-amplified neuroblastoma models primarily induces cytostatic effects rather than cytotoxicity, and tumors rapidly develop resistance through metabolic rewiring [4]. This evidence concerns the gene MYCN and neuroblastoma.